Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126183541 | 12618354 | 1 | I | 2016 | 20160726 | 20160803 | 20160803 | EXP | VN-009507513-1607VNM011076 | MERCK | 65.00 | YR | F | Y | 0.00000 | 20160803 | CN | VN | VN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126183541 | 12618354 | 1 | PS | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 50 MG (1 TABLET) DAILY | 20386 | 50 | MG | FILM-COATED TABLET | QD | ||||||
| 126183541 | 12618354 | 2 | SS | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 50 MG (1 TABLET) IN THE MORNING AND IN THE AFTERNOON | 20386 | 50 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126183541 | 12618354 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126183541 | 12618354 | Hypertension | |
| 126183541 | 12618354 | Inappropriate schedule of drug administration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126183541 | 12618354 | 1 | 20150901 | 2016 | 0 | |
| 126183541 | 12618354 | 2 | 2016 | 0 |